CoChat

Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer

Open access
Pedrote, Murilo M., de Oliveira, Guilherme A.P., Felix, Adriani L., Mota, Michelle F., Marques, Mayra de A., Soares, Iaci N., Iqbal, Anwar, Norberto, Douglas R., Gomes, Andre M.O., Gratton, Enrico, Cino, Elio A., Silva, Jerson L. · 2018 · Journal of Biological Chemistry
Cited by 50

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The functionality of the tumor suppressor p53 is altered in more than 50% of human cancers, and many individuals with cancer exhibit amyloid-like buildups of aggregated p53. An understanding of what triggers the pathogenic amyloid conversion of p53 is required for the further development of cancer therapies. Here, perturbation of the p53 core domain (p53C) with subdenaturing concentrations of guanidine hydrochloride and high hydrostatic pressure revealed native-like molten globule (MG) states, a subset of which were highly prone to amyloidogenic aggregation. We found that MG conformers of p53C, probably representing population-weighted averages of multiple states, have different volumetric properties, as determined by pressure perturbation and size-exclusion chromatography. We also found that they bind the fluorescent dye 4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid (bis-ANS) and have a native-like tertiary structure that occludes the single Trp residue in p53. Fluorescence experiments revealed conformational changes of the single Trp and Tyr residues before p53 unfolding and the presence of MG conformers, some of which were highly prone to aggregation. p53C exhibited marginal unfolding cooperativity, which could be modulated from unfolding to aggregation pathways with chemical or physical forces. We conclude that trapping amyloid precursor states in solution is a promising approach for understanding p53 aggregation in cancer. Our findings support the use of single-Trp fluorescence as a probe for evaluating p53 stability, effects of mutations, and the efficacy of therapeutics designed to stabilize p53.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.ra118.003285

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 50

Metadata

Authors
Pedrote, M. M., de Oliveira, G. A. P., Felix, A. L., Mota, M. F., Marques, M. D. A., Soares, I. N., Iqbal, A., Norberto, D. R., Gomes, A. M. O., Gratton, E., Cino, E. A., & Silva, J. L.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2018-07
Volume
293
Issue
29
Pages
11374-11387
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2805180952
Cited by
50
References
2
FWCI
1.65
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer. https://app.cochat.ai/papers/10.1074/jbc.ra118.003285
The paper
Pedrote, M. M., de Oliveira, G. A. P., Felix, A. L., Mota, M. F., Marques, M. D. A., Soares, I. N., Iqbal, A., Norberto, D. R., Gomes, A. M. O., Gratton, E., Cino, E. A., & Silva, J. L. (2018). Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.ra118.003285

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.